Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1970 1
1976 1
1986 1
1990 3
1991 3
1992 2
1993 3
1994 1
1995 4
1996 5
1997 6
1998 8
1999 4
2000 2
2001 4
2002 3
2003 4
2004 5
2005 3
2006 10
2007 10
2008 12
2009 9
2010 8
2011 12
2012 12
2013 11
2014 15
2015 24
2016 17
2017 31
2018 24
2019 10
2020 13
2021 17
2022 9
2023 9
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

280 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, Kudo M, Breder V, Merle P, Kaseb AO, Li D, Verret W, Xu DZ, Hernandez S, Liu J, Huang C, Mulla S, Wang Y, Lim HY, Zhu AX, Cheng AL; IMbrave150 Investigators. Finn RS, et al. N Engl J Med. 2020 May 14;382(20):1894-1905. doi: 10.1056/NEJMoa1915745. N Engl J Med. 2020. PMID: 32402160 Clinical Trial.
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, Yopp AC, Zhou J, Wang L, Wen X, Heo J, Tak WY, Nakamura S, Numata K, Uguen T, Hsiehchen D, Cha E, Hack SP, Lian Q, Ma N, Spahn JH, Wang Y, Wu C, Chow PKH; IMbrave050 investigators. Qin S, et al. Lancet. 2023 Nov 18;402(10415):1835-1847. doi: 10.1016/S0140-6736(23)01796-8. Epub 2023 Oct 20. Lancet. 2023. PMID: 37871608 Clinical Trial.
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.
Sangro B, Chan SL, Kelley RK, Lau G, Kudo M, Sukeepaisarnjaroen W, Yarchoan M, De Toni EN, Furuse J, Kang YK, Galle PR, Rimassa L, Heurgué A, Tam VC, Van Dao T, Thungappa SC, Breder V, Ostapenko Y, Reig M, Makowsky M, Paskow MJ, Gupta C, Kurland JF, Negro A, Abou-Alfa GK; HIMALAYA investigators. Sangro B, et al. Ann Oncol. 2024 May;35(5):448-457. doi: 10.1016/j.annonc.2024.02.005. Epub 2024 Feb 19. Ann Oncol. 2024. PMID: 38382875 Free article. Clinical Trial.
Radiation Emergency Medical Preparedness in Japan: A Survey of Nuclear Emergency Core Hospitals.
Nagata T, Arishima T, Yamaguchi Y, Hirohashi N, Usa T, Hasegawa A, Hanada H, Yamamoto N, Okamoto T, Akahoshi T, Hamada M, Abe T, Kikukawa M, Nakao H, Yamamura H, Sakamoto T, Akashi M, Hagihara A. Nagata T, et al. Among authors: hagihara a. Disaster Med Public Health Prep. 2022 Feb 7;17:e78. doi: 10.1017/dmp.2021.348. Disaster Med Public Health Prep. 2022. PMID: 35129102
Burnout among physicians in Poland.
Hagihara A, Murata S. Hagihara A, et al. Pol Arch Intern Med. 2021 Aug 30;131(7-8):612-614. doi: 10.20452/pamw.16068. Epub 2021 Aug 30. Pol Arch Intern Med. 2021. PMID: 34463080 Free article. No abstract available.
Influence of a biliary stent in patients with advanced pancreatic cancer treated with modified FOLFIRINOX.
Yoshikawa-Kimura A, Taira K, Maruyama H, Ishikawa-Kakiya Y, Yamamura M, Tanoue K, Hagihara A, Uchida-Kobayashi S, Enomoto M, Kimura K, Tanaka S, Amano R, Takemura S, Ohfuji S, Tanaka F, Nagami Y, Fujiwara Y. Yoshikawa-Kimura A, et al. Among authors: hagihara a. Medicine (Baltimore). 2022 Dec 9;101(49):e32150. doi: 10.1097/MD.0000000000032150. Medicine (Baltimore). 2022. PMID: 36626539 Free PMC article.
A Novel Heterozygous Missense Variant in the CIAO1 Gene in a Family with Alzheimer's Disease: The Val67Ile Variant Promotes the Interaction of CIAO1 and Amyloid-β Protein Precursor.
Nan H, Kim YJ, Tsuchiya M, Fukao T, Hara N, Hagihara A, Nishioka K, Hattori N, Hara N, Ikeuchi T, Ohtsuka T, Takiyama Y. Nan H, et al. Among authors: hagihara a. J Alzheimers Dis. 2021;84(2):599-605. doi: 10.3233/JAD-210706. J Alzheimers Dis. 2021. PMID: 34569959 Free PMC article.
280 results